Ocular Therapeutix, Inc. (OCUL)
NASDAQ: OCUL · Real-Time Price · USD
9.32
-0.20 (-2.10%)
At close: Apr 28, 2026, 4:00 PM EDT
9.50
+0.18 (1.93%)
After-hours: Apr 28, 2026, 7:14 PM EDT
Ocular Therapeutix Stock Forecast
Stock Price Forecast
The 9 analysts with 12-month price forecasts for Ocular Therapeutix stock have an average target of 23.56, with a low estimate of 18 and a high estimate of 31. The average target predicts an increase of 152.79% from the current stock price of 9.32.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Ocular Therapeutix stock from 9 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 4 | 5 | 5 |
| Buy | 6 | 6 | 6 | 6 | 6 | 4 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 10 | 10 | 10 | 10 | 11 | 9 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $21 | Strong Buy | Reiterates | $21 | +125.32% | Apr 13, 2026 |
| Clear Street | Clear Street | Strong Buy Maintains $21 → $28 | Strong Buy | Maintains | $21 → $28 | +200.43% | Mar 3, 2026 |
| Needham | Needham | Strong Buy Maintains $20 → $18 | Strong Buy | Maintains | $20 → $18 | +93.13% | Feb 20, 2026 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $21 | Strong Buy | Maintains | $21 | +125.32% | Feb 18, 2026 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $21 | Strong Buy | Maintains | $21 | +125.32% | Dec 9, 2025 |
Financial Forecast
Revenue This Year
56.07M
from 51.95M
Increased by 7.93%
Revenue Next Year
109.94M
from 56.07M
Increased by 96.07%
EPS This Year
-1.36
from -1.42
EPS Next Year
-1.26
from -1.36
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 62.0M | 290.9M | ||||||
| Avg | 56.1M | 109.9M | ||||||
| Low | 51.0M | 51.9M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 19.2% | 418.7% | ||||||
| Avg | 7.9% | 96.1% | ||||||
| Low | -1.9% | -7.4% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | -1.13 | -0.58 | ||||||
| Avg | -1.36 | -1.26 | ||||||
| Low | -1.68 | -1.87 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | - | - | ||||||
| Avg | - | - | ||||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.